Definitions

PURPOSE: This rule defines the terms used in this chapter. (1) Client is a person who meets eligibility requirements as defined by 19 CSR 40-7.050 Program Eligibility, and is approved for participation in the Metabolic Formula Program (MFP). (2) Department is the Missouri Department of Health and Senior Services. (3) The Metabolic Formula Program is a program of the department through which lowprotein formula, a special dietary product, is provided to individuals diagnosed as having phenylketonuria (PKU), maple syrup urine disease (MSUD) and other metabolic conditions as approved by the Newborn Screening Standing Committee. The Newborn Screening Standing Committee, a subcommittee of the Missouri Genetic Advisory Committee, makes recommendations on newborn screening issues. (4) Maple syrup urine disease (MSUD) is a metabolic disorder due to a defect in the enzyme that is responsible for the metabolism of the essential branched-chain amino acids isoleucine, leucine and valine. (5) Metabolic treatment center is a medical facility with the capacity to diagnose metabolic conditions and to provide comprehensive medical management. (6) Phenylketonuria (PKU) is a hereditary disorder of phenylalanine metabolism characterized by brain damage and mental retardation due to accumulation of toxic metabolic products. (7) Resident is an individual having a domicile in Missouri with the intention to live in Missouri on a permanent basis. (8) Sliding fee scale is the tool utilized to determine the monthly premium to be paid for the MFP program services. AUTHORITY: section 191.315, RSMo 2000 and sections 191.331 and 191.332, RSMo Supp. 2007.* Emergency rule filed Sept. 7, 2007, effective Sept. 17, 2007, expired March 14, 2008. Original rule filed Nov. 1, 2007, effective May 30, 2008. *Original authority: 191.315, RSMo 1985, amended 1993, 1995; 191.331, RSMo 1965, amended 1985, 1992, 1993, 1995, 1997, 2007; and 191.332, RSMo 2001, amended 2005.